Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

3 Jan 2014 08:12

RNS Number : 8522W
HICL Infrastructure Company Ld
03 January 2014
 



3 January 2014

HICL INFRASTRUCTURE COMPANY LIMITED

Further to the recent scrip dividend circular and In accordance with DTR 3.1.2R, the beneficial interests of the Directors in the issued share capital of the Company are as follows:

Director

Number of Ordinary Shares acquired as a result of the Scrip Dividend

Total holding following the Scrip Dividend

% of issued share capital

Graham Picken

Held in Spouse name - purchased 23.12.2013

 

3,294

0

126,663

110,000

Total holding 236,663

 

 

0.0199%

Chris Russell

Held in family name

 

0

0

61,965

31,930

Total holding 93,895

 

 

0.0079%

John Hallam

 

0

117,736

0.0099%

Susie Farnon

 

0

19,000

0.0016%

Ian Russell

 

0

37,880

0.0032%

Sarah Evans

Held in Spouse name

1,816

0

69,831

181,665

Total holding 251,496

 

 

0.0211%

In accordance with DTR 3.1.2R, the beneficial interests of the senior executives of the Investment Adviser with day-to-day management responsibility in connection with services provided to the Group (being the Company and its wholly owned corporate subsidiaries) are as follows:

Executive

Number of Ordinary Shares acquired as a result of the Scrip Dividend

Total holding following the Scrip Dividend

% of issued share capital

Erwan Fournis

Joint with Spouse

 

0

6,676

0.0006%

Mark Woodhams

 

5,314

205,314

0.0172%

Keith Pickard

 

1,277

49,114

0.0041%

Chris Gill

Held in Spouse name

 

0

19,016

0.0016%

Gareth Craig

 

0

96,331

0.0081%

Tony Roper

 

1,346

51,769

0.0043%

Werner von Guionneau

16,025

616,113

0.0518%

 

The total number of voting rights in the Company is 1,190,391,625 Shareholders may use this figure as the denominator for the calculations by which they determine whether they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

For further information, please contact:

 

Dexion Capital (Guernsey) Limited 01481 743 940

Gillian Newton / Christopher Copperwaite

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDBDBGBGSX

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.